Page 4 - Inopharm News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Inopharm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Inopharm Today - Breaking & Trending Today
(Photo courtesy of ORCA Cold Chain Solutions) MANILA - ORCA Cold Chain Solutions, a pioneering cold storage company in the Philippines, is listing with the Philippine Stock Exchange to raise funds for its expansion program as it aims to seize opportunities in the growing industry. In a statement Thursday, ORCA said it plans to sell 1,480,000,000 shares with an offer price set at PHP0.88 per share. "The company intends to use the net proceeds, estimated to be PHP841.1 million, for land acquisition, expansion of existing facilities to accommodate additional value-added services, development of new cold storage facilities, and general corporate purposes," the company said. Currently, ORCA has two subsidiaries Arendelle Cold Logisitics, Inc. in Taguig and Eisberg Cold Logistics, Inc. in Caloocan with a combined capacity of 34,342 pallet positions, or equivalent to 34.3 million kilograms. According to Cold Chain Association of the Philippines, the cold storage industry has a t ....
Majority of the vaccines, whose value grosses Shs200b, were donated by Western nations, with the United States leading. News of the expiration when millions of Ugandans are either unvaccinated or. ....
(Anadolu photo) GENEVA - The World Health Organization on Thursday approved Convidecia, a vaccine manufactured by China's CanSino Biologics, as the 11th approved vaccine to prevent the spread of Covid-19. In a statement, the UN health agency said Convidecia was assessed under its emergency use listing procedure, based on the review of data on quality, safety, efficacy, a risk management plan, programmatic suitability and a manufacturing site inspection. "The Technical Advisory Group for Emergency Use Listing, convened by WHO and made up of regulatory experts from around the world, has determined that the vaccine meets the WHO standards for protection against Covid-19 and that the benefits of the vaccine far outweigh risks," the press release said. It added that the single-dose vaccine was also reviewed by WHO's Strategic Advisory Group of Experts on Immunization (SAGE), which has recommended its use in all age groups 18 and above. "Convidecia was found to have 64 ....